Statin Use and Risk of Pancreatic Cancer: An Updated Meta-analysis of 26 Studies
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Objective: The aim of this study was to explore the relationship between statin use and the risk of pancreatic cancer. Methods: Electronic databases were searched to identify relevant studies published until January 2018. The pooled relative risks (RRs) and 95% confidence intervals (CIs) were calculated with random-effects model. Subgroup analyses and sensitivity analysis were also conducted. Cochran Q test and I 2 statistic were used to evaluate the heterogeneity. Results: Twenty-six studies were included that contained more than 3 million participants and 170,000 pancreatic cancer patients. The overall result demonstrated a significant decrease in pancreatic cancer risk with statin use (RR, 0.84; 95% CI, 0.73–0.97; P = 0.000; I 2 = 84.4%). In subgroup analyses, nonsignificant association was detected between long-term statin use and the risk of pancreatic cancer (RR, 0.98; 95% CI, 0.86–1.11; P = 0.718; I 2 = 0.0%). Meanwhile, there was nonsignificant association between the use of lipophilic statins and the risk of pancreatic cancer (RR, 0.98; 95% CI, 0.84–1.15; P = 0.853; I 2 = 27.2%). No publication bias was found in this meta-analysis. Conclusions: The overall result of this meta-analysis supports the hypothesis that statins have a protective effect on pancreatic cancer. Furthermore, high-quality randomized clinical trials and cohort studies are needed to confirm these findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Hidalgo, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901557 · Cited by 2,570
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Initiative, A. P. C. G., Biankin, A. V., Waddell, N., Kassahn, K. S., Gingras, M.-C., Muthuswamy, L. B., Johns, A. L., Miller, D. K., Wilson, P. J., Patch, A.-M., et al. (2012) · Nature · doi:10.1038/nature11547 · Cited by 2,058
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals
Canto, M. I., Hruban, R. H., Fishman, E. K., Kamel, I. R., Schulick, R., Zhang, Z., Topazian, M., Takahashi, N., Fletcher, J., Petersen, G., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.01.005 · Cited by 648
Cited by
Dorsch, M., Kowalczyk, M., Planque, M., Heilmann, G., Urban, S., Dujardin, P., Forster, J., Ueffing, K., Nothdurft, S., Oeck, S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110056 · Cited by 55
Zhang, J., Fu, S., Liu, D., Wang, Y., & Tan, Y. (2023) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002517 · Cited by 27
(2023) · PubMed Central · Cited by 15
Long-term use of anti-cholesterol drugs and cancer risks in a Japanese population
Okita, Y., Sobue, T., Zha, L., Kitamura, T., Iwasaki, M., Inoue, M., Yamaji, T., Tsugane, S., & Sawada, N. (2024) · Scientific Reports · doi:10.1038/s41598-024-53252-4 · Cited by 14
Teper, Y., Ye, L., Waldron, R. T., Lugea, A., Sun, X., Sinnett-Smith, J., Hines, O. J., Pandol, S. J., Rozengurt, E., & Eibl, G. (2023) · Scientific Reports · doi:10.1038/s41598-023-43498-9 · Cited by 10
Metadata
- Authors
- Zhang, Y., Liang, M., Sun, C., Qu, G., Shi, T., Min, M., Wu, Y., & Sun, Y.
- Venue
- Pancreas
- Published
- 2019-02
- Volume
- 48
- Issue
- 2
- Pages
- 142-150
- ISSN
- 0885-3177 (ISSN-L)
- 1536-4828
- OpenAlex
- W2911988124
- Cited by
- 81
- References
- 4
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Statin Use and Risk of Pancreatic Cancer: An Updated Meta-analysis of 26 Studies. https://app.cochat.ai/papers/10.1097/mpa.0000000000001226
- The paper
- Zhang, Y., Liang, M., Sun, C., Qu, G., Shi, T., Min, M., Wu, Y., & Sun, Y. (2019). Statin Use and Risk of Pancreatic Cancer: An Updated Meta-analysis of 26 Studies. Pancreas. https://doi.org/10.1097/mpa.0000000000001226
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.